ARTICLE | Company News
Serono gets U.S. approval for Ovidrel
October 2, 2000 7:00 AM UTC
Serono (SWX:SEO; SRA) received FDA marketing approval for Ovidrel choriogonadotropin injection for the treatment of infertility. SEO plans to launch the product in the U.S. by the first quarter 2001, ...